PATENT CLAIM ANALYSIS

Application Number: 15865847
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-02
Patent Classification: ["514", "507000"]

Abstract:
The present invention relates to the treatment of solid tumors in humans such as cancer, especially colorectal cancer (CRC), which involves administering multiple boluses of the diastereomerically pure folate adjuvant [6R]-5,10-methylenetetrahydrofolate in 5-fluorouracil (5-FU) based chemotherapy.

Claim (Index 2):
The method according to  claim 1 , wherein the solid tumor is a cancer form selected from colon cancer, stomach cancer, breast cancer, bowel cancer, gallbladder cancer, lung cancer (specifically adenocarcinoma), colorectal cancer (CRC) including metastatic CRC, head and neck cancer, liver cancer, osteosarcoma and pancreatic cancer.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 1.17949
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15114690', '14372701', '12805287', '14811905', '13002758']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.747431399802114
- 35 USC 102 Novelty (BERT): 0.5273163182263888
- Combined Prediction Score: 0.7254198916445415
- Mean Citation Score: 265.23253
- Max Citation Score: 315.36057
- Similarity Product: 232.2157368924701

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test